Sterling Capital Management
UTMD icon

Sterling Capital Management’s Utah Medical Products UTMD Stock Holding History

Sterling Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.44K Buy
60
+3
+5% +$214 ﹤0.01% 2917
2026
Q2 		$3.93K Sell
57
-43
-43% -$2.86K ﹤0.01% 2748
2026
Q1 		$6.2K Sell
100
-74
-43% -$4.66K ﹤0.01% 2626
2025
Q4 		$9.7K Sell
174
-37
-18% -$2.14K ﹤0.01% 2613
2025
Q3 		$13.3K Buy
211
+122
+137% +$7.22K ﹤0.01% 2341
2025
Q2 		$5.07K Buy
89
+35
+65% +$1.9K ﹤0.01% 2507
2025
Q1 		$3.03K Sell
54
-53
-50% -$3.18K ﹤0.01% 2409
2024
Q4 		$6.58K Buy
107
+96
+873% +$6.21K ﹤0.01% 2336
2024
Q3 		$736 Buy
+11
New +$747 ﹤0.01% 2692

Other funds holding UTMD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Cardinal Capital Management Inc (North Carolina)
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return
O'Shaughnessy Asset Management
O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Sterling Capital Management's UTMD Position: Q3 2026 in Review

Sterling Capital Management increased its Utah Medical Products (UTMD) stake by 5.3% in Q3 2026, buying an estimated $214 and bringing the position to 60 shares worth $4.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

Sterling Capital Management first reported a position in UTMD in Q3 2024 and has held it in 9 quarters since. The position peaked at $13.3K in Q3 2025. 74 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Sterling Capital Management held 60 shares of Utah Medical Products worth $4.44K as of Q3 2026.
  • Sterling Capital Management bought 3 Utah Medical Products shares in Q3 2026, an estimated $214.
  • Utah Medical Products made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2917 holding.
  • Sterling Capital Management first reported a position in Utah Medical Products in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's Utah Medical Products position peaked at $13.3K in Q3 2025.
  • 74 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.